bn 50726 has been researched along with erythrosine in 1 studies
| Studies (bn 50726) | Trials (bn 50726) | Recent Studies (post-2010) (bn 50726) | Studies (erythrosine) | Trials (erythrosine) | Recent Studies (post-2010) (erythrosine) |
|---|---|---|---|---|---|
| 10 | 0 | 0 | 15,483 | 108 | 2,574 |
| Protein | Taxonomy | bn 50726 (IC50) | erythrosine (IC50) |
|---|---|---|---|
| Genome polyprotein | Zika virus | 1.7 | |
| large T antigen | Betapolyomavirus macacae | 13.04 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bazan, HE; Bazan, NG; Braquet, P; Lin, N | 1 |
1 other study(ies) available for bn 50726 and erythrosine
| Article | Year |
|---|---|
Prolonged effect of a new platelet-activating factor antagonist on ocular vascular permeability in an endotoxin model of uveitis.
Topics: Animals; Azepines; Capillary Permeability; Cornea; Dextrans; Endotoxins; Eye; Fluoresceins; Injections; Keratitis; Platelet Activating Factor; Rabbits; Thienopyridines; Uveitis | 1991 |